Skip to main content

Diuretics may increase risk of renal cell carcinoma

Cancer Causes & Control volume 3, pages 309–312 (1992)Cite this article

Abstract

The risk for kidney cancer was examined in a Danish cohort of 192,133 people on a hospital discharge register who had been given a diagnosis of hypertension, heart failure, or edema, and were presumed to be probable users of diuretics. The subjects were identified from 1977 to 1987 and followed-up for cancer through 1987. A total of 10,630 cancers was observed. While the risk for all cancers was increased slightly (standard mortality ratio [SMR]=122, 95 percent confidence interval [CI]=120–124), the risk for renal cell carcinoma was more than doubled (SMRmen=221, CI=192–253; SMRwomen=246, CI=213–283). Increased risks were found in all age groups, and, although surveillance bias was present initially, the risk increased consistently in the years following discharge. Risk estimates for individuals discharged with hypertension were similar to those for the total cohort. Use of diuretics was validated in a random sample of 100 individuals. More than 70 percent were taking diuretics at the time of discharge. The increased risk for renal cell carcinoma in this cohort may indicate either that diuretics are involved in the etiology of renal cell carcinoma or that the risk can be attributed to confounders, including smoking, which affect risk for both the discharge diagnosis and renal cell carcinoma.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Jensen, OM, Knudsen, JB, McLaughlin, JK, et al. The Copenhagen case-referent study of renal pelvis and ureter cancer: the role of smoking and occupational exposures. Int J Cancer 1988; 41: 557–61.

    Google Scholar 

  2. IARC Working Group. Phenacetin and mixtures containing phenacetin. Lyon, France: International Agency for Research on Cancer, 1987; IARC Monographs suppl. 7: 310–2.

    Google Scholar 

  3. Armstrong, B, Garrod, A, Doll, R. A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer 1976; 33: 127–36.

    Google Scholar 

  4. Yu, MC, Mack, TM, Hanish, R, et al. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. JNCI 1986; 77: 351–6.

    Google Scholar 

  5. McLaughlin, JK, Mandel, JS, Blot, WJ, et al. Population based case-control study of renal cell carcinoma. JNCI 1984; 72: 275–84.

    Google Scholar 

  6. McLaughlin, JK, Blot, WJ, Fraumeni, JF. Diuretics and renal cell carcinoma. JNCI 1988; 80: 378.

    Google Scholar 

  7. McCredie, M, Ford, JM, Stewart, JH. Risk factors for cancer of the renal parenchyma. Int J Cancer 1988; 42: 13–6.

    Google Scholar 

  8. Asal, NR, Risser, DR, Kadami, S, et al. Risk factors in renal cell carcinoma. I. Methodology, demographics, tobacco, beverage use, and obesity. Cancer Det Prev 1988; 11: 359–77.

    Google Scholar 

  9. Grove, JS, Nomura, A, Severson, RK, Stemmermann, GN. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991; 134: 942–7.

    Google Scholar 

  10. World Health Organization. International Classification of Diseases, Injuries and Causes of Death. Eighth Revision (1968). Geneva: WHO, 1969.

    Google Scholar 

  11. Storm, HH, Manders, T, Sprøgel, P, et al. Cancer Indicidence in Denmark 1987. Copenhagen: Danish Cancer Society, 1990.

    Google Scholar 

  12. Kirchner, FK, Braren, V, Smith, C, et al. Renal carcinoma discovered incidentally by arteriography during evaluation for hypertension, J Urol 1976; 115: 643–5.

    Google Scholar 

  13. Sufrin, G, Murphy, GP. Renal adenocarcinoma. Urol Surveys 1980; 30: 129–44.

    Google Scholar 

  14. Appleyard M (ed.). The Copenhagen City Heart Study. Scan J Soc Med 1989; Suppl. 41: 113.

  15. Fraser, GE, Phillips, RL, Beeson, WL. Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-day Adventists. Int J Epidemiol 1990: 19; 832–8.

    Google Scholar 

  16. Selby, JV, Friedman, GD, Fireman, BH. Screening prescription drugs for possible carcinogenicity: 11–15 years of follow-up. Cancer Res 1989; 49: 5736–47.

    Google Scholar 

  17. Lijinsky, W, Reuber, MD. Pathological effects of chronic administration of chlorothiazide, with and without sodium nitrite, to F344 rats. Toxicol Ind Health 1987; 3: 413–22.

    Google Scholar 

  18. National Toxicology Program. Toxicology and Carcinogenesis Studies of Hydroclorothiazide in F344/N Rats and B6C3F Mice. NTP Technical Report No. 357. Research Triangle Park, North Carolina, 1989.

  19. National Toxicology Program. Toxicology and carcinogenesis studies of furosemide in F344/N rates and B6C3F mice. NTP Technical Report No. 356. Research Triangle Park, North Carolina, 1989.

Download references

Authors
  1. Anders Mellemgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henrik Møller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jørgen H. Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Authors are with the Danish Cancer Registry, Danish Cancer Society, Rosenvængets Hovedvej 38, Box 839 Copenhagen DK-2100ø, Denmark. Address correspondence to Dr Mellemgaard.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mellemgaard, A., Møller, H. & Olsen, J.H. Diuretics may increase risk of renal cell carcinoma. Cancer Causes Control 3, 309–312 (1992). https://doi.org/10.1007/BF00146883

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00146883

Key words

  • Cohort study
  • Denmark
  • diuretics
  • kidney cancer
  • renal cell carcinoma